product Name:protoveratrine
- Protoveratrine A; 4-21-00-06845 (Beilstein Handbook Reference); BRN 0077415; NSC 23865; NSC 7526; Protalba; Protofecaterine A; Protoveratrin; Protoveratrine; Puroverine; UNII-XP343X1HJU; (3beta(S),4alpha,6alpha,7alpha,15alpha(R),16beta)-4,9-Epoxycevane-3,4,6,7,14,15,16,20-octol 6,7-diacetate 3-(2-hydroxy-2-methylbutyrate) 15-(2-methylbutyrate); Cevane-3,4,6,7,14,15,16,20-octol, 4,9-epoxy-, 6,7-diacetate 3-(2-hydroxy-2-methylbutanoate) 15-(2-methylbutanoate), (3beta(S),4alpha,6alpha,7alpha,15alpha(R),16beta)- (9CI); Cevane-3-beta,4-beta,6-alpha,7-alpha,14,15-alpha-16-beta,20-octol, 4,9-epoxy-, 6,7-diacetate 3-((+)-2-hydroxy-2-methylbutyrate) 15-((-)-2-methylbutyrate); Cevane-3beta,4beta,6alpha,7alpha,14,15alpha,16beta,20-octol, 4,9-epoxy-, 6,7-diacetate 3-((+)-2-hydroxy-2-methylbutyrate) 15-((-)-2-methylbutyrate) (8CI); (3beta,4alpha,6alpha,7alpha,9beta,15alpha,16beta)-6,7-bis(acetyloxy)-4,14,16,20-tetrahydroxy-15-{[(2R)-2-methylbutanoyl]oxy}-4,9-epoxycevan-3-yl (2S)-2-hydroxy-2-methylbutanoate; (3beta,4alpha,6alpha,7alpha,9xi,15alpha,16beta)-6,7-bis(acetyloxy)-4,14,16,20-tetrahydroxy-15-{[(2R)-2-methylbutanoyl]oxy}-4,9-epoxycevan-3-yl (2S)-2-hydroxy-2-methylbutanoate; (4beta,5xi,7beta,8xi,10alpha,12xi,13xi,14beta,15beta,16alpha,17xi,20beta,22xi,25xi)-6,7-bis(acetyloxy)-4,14,16,20-tetrahydroxy-15-[(2-methylbutanoyl)oxy]-4,9-epoxycevan-3-yl 2-hydroxy-2-methylbutanoate; (3beta,4alpha,6alpha,7alpha,9beta,12xi,15alpha,16beta)-6,7-bis(acetyloxy)-4,14,16,20-tetrahydroxy-15-{[(2R)-2-methylbutanoyl]oxy}-4,9-epoxycevan-3-yl 2-hydroxy-2-methylbutanoate
- 143-57-7
- 205-602-9
- C41H63NO14
- 793.9372
- InChI=1/C41H63NO14/c1-10-20(4)34(46)55-33-28(45)27-23(18-42-17-19(3)12-13-25(42)38(27,9)49)24-16-39-32(40(24,33)50)30(53-22(6)44)29(52-21(5)43)31-36(39,7)15-14-26(41(31,51)56-39)54-35(47)37(8,48)11-2/h19-20,23-33,45,48-51H,10-18H2,1-9H3/t19-,20+,23-,24?,25-,26-,27+,28+,29-,30+,31-,32+,33-,36-,37?,38+,39-,40-,41-/m0/s1
- 1.36g/cm3
- 810.6°C at 760 mmHg
- 1.594
- 444°C
- 2.04E-30mmHg at 25°C
-
-
-
Home